shemp
a flimsy character...perfidious and despised
Oy vey.
The biopharma company Cassava Sciences announced today its experimental Alzheimer’s disease drug simufilam showed no signs of working in a phase 3 clinical trial. Volunteers who took the drug performed no better in cognitive or everyday-life activities than those who received a placebo. The announcement appears to mark the end of the company’s development of simufilam for Alzheimer’s, which has been marked by scandal and controversy.
“This is an expected result,” says Matthew Schrag, a Vanderbilt University neuroscientist who discovered many of the apparently doctored images cited in the complaint to FDA. “It remains alarming to me that the trial was permitted to continue to completion in view of the serious ethical concerns around the underlying science.” Schrag, who has conducted his assessments of Cassava’s work separately from his university duties, provided much of the basis for the citizen’s petition to FDA and has tracked the company since.
Elisabeth Bik, a leading forensic image sleuth, also identified many of the problems in Cassava’s studies—and was relentlessly attacked by boosters of the company on social media. The self-described “SAVAges,” a play on the company stock-ticker symbol, had for years lambasted Bik and other Cassava critics, including journalists who wrote about the company, in often-caustic and at-times threatening terms.
The company has only one drug in development, making its future uncertain at best. Its stock plummeted by more than 80% on the news—dropping about $1 billion in value.
“This is by no means the news we were hoping for,” Rick Barry, the company’s CEO, said in a conference call.
This part:Apparently this Alzheimer's treatment was known to be without any merit long before the trials in which it apparently failed miserably. This is an article by Charles Piller who apparently has a book out about all kinds of other false promises when it comes to Alzheimers. Seems that fraud and hype are rife in this area.
So who are these "SAVAges"? Perhaps they'd like a little taste of their own medicine (pun intendedElisabeth Bik, a leading forensic image sleuth, also identified many of the problems in Cassava’s studies—and was relentlessly attacked by boosters of the company on social media. The self-described “SAVAges,” a play on the company stock-ticker symbol, had for years lambasted Bik and other Cassava critics, including journalists who wrote about the company, in often-caustic and at-times threatening terms.
This part:
So who are these "SAVAges"? Perhaps they'd like a little taste of their own medicine (pun intended)?
Bik is a hero.
Yeah, she is.This part:
So who are these "SAVAges"? Perhaps they'd like a little taste of their own medicine (pun intended)?
Bik is a hero.
He'll be more likely to make it easier for the fraudsters to thrive. He has a serious grá for fraudulent "medicine".Maybe this is something positive that RFK Jr's efforts can be actually employed to eradicate. If he concentrates solely on cleaning up this field properly, I'll give him props. Rather than dicking about killing US children by stupidly slowing or even withholding proven vaccines.
retractionwatch.com
That list only surprised me in that the Chinese have beaten KPR into fourth place.New article in Nature:
![]()
Exclusive: These universities have the most retracted scientific articles
A first-of-its-kind analysis by Nature reveals which institutions are retraction hotspots.www.nature.com
Hopefully greater awareness of the problem will eventually lead to policies that discourage fakery and tools that can spot it when it does occur.
From the Academy's by-laws:![]()
Misinformation Doctors Start a Misinformation Journal to Spread Misinformation
There is no doubt the "studies" in this journal will conclude We Want Them Infected doctors were right about everything the whole time; mitigation measure were an epic catastrophe while COVID was a hasciencebasedmedicine.org
I'm not sure if that was sarcastic or not, but I am serious.That's a dangerous thing to post in the current climate: people might think you're serious.
It seems like he wants to have it both ways.So let’s be clear what happened here. In the mRNA trials, 39 of the 40 severe cases occurred in the placebo group. While these were obviously amazing results, the vaccine and the virus were still brand new. Dr. Bhattacharya overhyped the vaccines, claiming they blocked transmission, obviated severe disease, and had “defanged” the pandemic. He mocked anyone who wisely took a more conservative approach.
Today, Dr. Bhattacharya, denies that the mRNA vaccines limit severe disease and wants them removed from the market. He excoriates others for his words, blaming them for vaccine-hesitancy and a loss of trust.
But, but, WAAAAA! DEI!That's all well and good. However, I will pay more attention to "the quality and extent of their already published publichealth work"
It seems like he wants to have it both ways.
Obviously "discrimination based on" the laundry list of irrelevancies cited there is dumb, but who even does that?
Yeah, I had the same thought. I think AI might notice unusual patterns that would likely escape the attention of a human being. Like, maybe hallmarks of data that is faked compared to real data. (Among other things that might be red flags or yellow flags)Wonder if this is a good area for current AI approaches to deal with? Spotting patterns and similarities in large data is something they are very good at.
Wonder if this is a good area for current AI approaches to deal with? Spotting patterns and similarities in large data is something they are very good at.